These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 10558966

  • 1. Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.
    Pereira AS, Kashuba AD, Fiscus SA, Hall JE, Tidwell RR, Troiani L, Dunn JA, Eron JJ, Cohen MS.
    J Infect Dis; 1999 Dec; 180(6):2039-43. PubMed ID: 10558966
    [Abstract] [Full Text] [Related]

  • 2. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
    Ghosn J, Chaix ML, Peytavin G, Bresson JL, Galimand J, Girard PM, Raffi F, Cohen-Codar I, Delfraissy JF, Rouzioux C.
    J Antimicrob Chemother; 2008 Jun; 61(6):1344-7. PubMed ID: 18343806
    [Abstract] [Full Text] [Related]

  • 3. The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
    Eron JJ, Smeaton LM, Fiscus SA, Gulick RM, Currier JS, Lennox JL, D'Aquila RT, Rogers MD, Tung R, Murphy RL.
    J Infect Dis; 2000 May; 181(5):1622-8. PubMed ID: 10783117
    [Abstract] [Full Text] [Related]

  • 4. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma.
    Lorello G, la Porte C, Pilon R, Zhang G, Karnauchow T, MacPherson P.
    HIV Med; 2009 Oct; 10(9):548-54. PubMed ID: 19515092
    [Abstract] [Full Text] [Related]

  • 5. Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.
    Goodgame JC, Pottage JC, Jablonowski H, Hardy WD, Stein A, Fischl M, Morrow P, Feinberg J, Brothers CH, Vafidis I, Nacci P, Yeo J, Pedneault L.
    Antivir Ther; 2000 Sep; 5(3):215-25. PubMed ID: 11075942
    [Abstract] [Full Text] [Related]

  • 6. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
    Zhang H, Dornadula G, Beumont M, Livornese L, Van Uitert B, Henning K, Pomerantz RJ.
    N Engl J Med; 1998 Dec 17; 339(25):1803-9. PubMed ID: 9854115
    [Abstract] [Full Text] [Related]

  • 7. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
    Celum CL, Buchbinder SP, Donnell D, Douglas JM, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW.
    J Infect Dis; 2001 Jan 01; 183(1):23-35. PubMed ID: 11106536
    [Abstract] [Full Text] [Related]

  • 8. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar 10; 14(4):367-74. PubMed ID: 10770538
    [Abstract] [Full Text] [Related]

  • 9. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.
    Marcelin AG, Tubiana R, Lambert-Niclot S, Lefebvre G, Dominguez S, Bonmarchand M, Vauthier-Brouzes D, Marguet F, Mousset-Simeon N, Peytavin G, Poirot C.
    AIDS; 2008 Aug 20; 22(13):1677-9. PubMed ID: 18670231
    [Abstract] [Full Text] [Related]

  • 10. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
    Gartland M, AVANTI Study Group.
    Antivir Ther; 2001 Jun 20; 6(2):127-34. PubMed ID: 11491417
    [Abstract] [Full Text] [Related]

  • 11. Amount of seminal IL-1beta positively correlates to HIV-1 load in the semen of infected patients.
    Berlier W, Bourlet T, Lévy R, Lucht F, Pozzetto B, Delézay O.
    J Clin Virol; 2006 Jul 20; 36(3):204-7. PubMed ID: 16730226
    [Abstract] [Full Text] [Related]

  • 12. Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen.
    Lowe SH, van Leeuwen E, Droste JA, van der Veen F, Reiss P, Lange JM, Burger DM, Repping S, Prins JM.
    Ther Drug Monit; 2007 Oct 20; 29(5):566-70. PubMed ID: 17898645
    [Abstract] [Full Text] [Related]

  • 13. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM, Chêuc G, Ferchal F, Journot V, Pellegrin I, Sombardier MN, Rancinan C, Cotte L, Madelaine I, Debord T, Decazes JM, ALBI (ANRS 070) Study Group.
    Antivir Ther; 1999 Oct 20; 4 Suppl 3():71-4. PubMed ID: 16021874
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection.
    Liuzzi G, Chirianni A, Bagnarelli P, Clementi M, Piazza M.
    Antivir Ther; 1999 Oct 20; 4(2):95-9. PubMed ID: 10682154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy.
    Mayer KH, Boswell S, Goldstein R, Lo W, Xu C, Tucker L, DePasquale MP, D'Aquila R, Anderson DJ.
    Clin Infect Dis; 1999 Jun 20; 28(6):1252-9. PubMed ID: 10451162
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.